| Model Number |
638BL32 |
| Medical Device Problem Code |
Break (1069)
|
| Health Effect - Clinical Code |
Insufficient Information (4580)
|
| Date of Event |
03/19/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Medtronic received information that during the implant of this 32mm mitral annuloplasty band, it was replaced with a 32mm annuloplasty band of the same model.The reason for the replacement was reported as the buckle suture on the annuloplasty ring holder was broken.The broken buckle suture interfered with implant of the annuloplasty band, and after several unsuccessful attempts, a new device was used instead.No additional adverse patient effects were reported.
|
| |
|
Additional Manufacturer Narrative
|
|
Section updated: b.5 medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Additional information received reported that the inner and outer packaging of the annuloplasty band was intact.The device was not fully sutured and tested prior to removal due to the suture breakage.No additional adverse patient effects were reported.
|
| |
|
Additional Manufacturer Narrative
|
|
Product analysis: upon receipt at medtronic's quality laboratory, visual examination revealed that the band appeared slightly discolored, possibly from blood contact.There were no damages observed, nor cuts or scratches on the band.The cg band holder was not returned for analysis.Conclusion: the investigation is in progress.A supplemental report will be submitted after completion of the investigation.D9: updated.H3: device evaluated.Updated h6: coding updated.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Product analysis: upon receipt at medtronic's quality laboratory, visual examination revealed that the band appeared slightly discolored, possibly from blood contact.There were no damages observed, nor cuts or scratches on the band.The cg band holder was not returned for analysis.Conclusion: the dhr review was performed on the device; there were no issues identified during manufacturing that could have impacted this event.The device was manufactured per approved and released manufacturing processes and the device met all applicable manufacturing specifications prior to release for distribution.Without the return of the holder, the cause of the complaint can not be determined.The investigation was completed with the information that was provided.Medtronic will continue to monitor field performance for similar events should they occur.Updated data: h.6.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|